Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
936.00    4.00 (0.43%)
Bid:
936.00
Ask:
952.00
Spread: 16.00 (1.709%)
Market Cap: £256.19m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

Acquisition

7 Feb 2006 07:02

Gooch & Housego PLC07 February 2006 For Immediate Release 7 February 2006 Gooch & Housego PLC ACQUISITION OF CHROMODYNAMICS, INC. Gooch & Housego, the specialist manufacturer of advanced optoelectroniccomponents, materials, instruments and systems, is pleased to announce that ithas acquired ChromoDynamics, Inc. (CDI). Based in the USA, CDI is a developer ofhyperspectral imaging systems. Designed initially for use in conjunction withhigh-end research microscopes, the products are targeted at biomedical research,drug development and medical diagnostics. Future products will address a broadrange of applications including remote sensing and semiconductor inspectionsystems. CDI was founded in 1997 to transfer technology developed at Carnegie MellonUniversity ("CMU"), Pittsburgh, Pennsylvania, into the commercial realm, andbenefited from grants from the National Institutes of Health (NIH) and otherfunding bodies. CDI licenses key patents from CMU (exclusive to its targetmarkets) and has also developed its own intellectual property. Biomedicalimaging systems based on this technology have the potential to improve detectionof cancer and aid in drug development. Three first generation products have beensold to leading biomedical research and pharmaceutical organisations, and afourth to a manufacturer of semiconductor inspection equipment. CDI is now ready to commercialise the technology and make the transition fromresearch and development to production. Manufacturing resources and expertisewithin Gooch & Housego in acousto-optic tuneable filters (the key activecomponent in the system), spectroscopic instrumentation and electronics willenable CDI to achieve the scale necessary to address the market opportunity.Initial sales are expected in the 2007 financial year. The current sole employeeand co-founder will remain with CDI as Vice President of R&D and will providethe foundation for the new team. The consideration for the acquisition is $1,180,000 payable in cash oncompletion. During the year to 30 June 2005, CDI had an income of $229k and made a loss of$78,000. As at 31 May 2005, CDI had net assets of $26,000. Contacts: Gareth Jones, Chairman and Chief Executive Officer, 01460 52271 Tim Thompson, Buchanan Communication Ltd, 020 7466 5000 Andrew Edwards, Oriel Securities Limited, 020 7710 7600 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
9th May 20197:00 amRNSNotification of Half Year Results
30th Apr 20197:00 amRNSAppointment of Chief Financial Officer
9th Apr 20197:00 amRNSCapital Markets Day
9th Apr 20197:00 amRNSHalf Year Trading Update
28th Mar 20195:28 pmRNSDirector/PDMR Shareholding
28th Mar 20195:25 pmRNSDirector/PDMR Shareholding
28th Mar 20195:24 pmRNSDirector/PDMR Shareholding
25th Mar 20195:24 pmRNSDirector/PDMR Shareholding
13th Mar 20197:00 amRNSITL signs manufacturing agreement with OrganOx
25th Feb 201911:27 amRNSDirector Share Purchase
21st Feb 20192:58 pmRNSDirector Share Purchase
20th Feb 20191:07 pmRNSResult of AGM
20th Feb 20197:00 amRNSAGM Trading Update
9th Jan 201910:17 amRNSGrant of LTIP Awards
9th Jan 20197:00 amRNSSite Visit to ITL Life Science Business
28th Dec 201811:14 amRNSBlock Listing Six Monthly Return
28th Dec 201811:13 amRNSIssue of Equity and Total Voting Rights
28th Dec 201811:12 amRNSBlock Listing Application
11th Dec 20184:44 pmRNSAdditional Listing
11th Dec 20187:00 amRNSPosting of Annual Report and AGM Notice
5th Dec 201811:30 amRNSDirector/PDMR Shareholding
5th Dec 201811:28 amRNSDirector/PDMR Shareholding
27th Nov 201811:36 amRNSDirector/PDMR Shareholding
27th Nov 20187:00 amRNSCFO Succession
27th Nov 20187:00 amRNSPreliminary Results
30th Oct 201811:06 amRNSHolding(s) in Company
29th Oct 201811:08 amRNSHolding(s) in Company
25th Oct 20184:40 pmRNSHolding(s) in Company
25th Oct 20187:00 amRNSNotification of Preliminary Results
23rd Oct 201810:23 amRNSHolding(s) in Company
4th Oct 20187:00 amRNSFull Year Trading Update
26th Sep 20189:00 amRNSHolding(s) in Company
6th Sep 20187:00 amRNSAerospace and Defence Acquisition
8th Aug 20187:00 amRNSLife Sciences Acquisition
12th Jul 20189:26 amRNSHolding(s) in Company
13th Jun 201810:08 amRNSHolding(s) in Company
6th Jun 20182:02 pmRNSDirector/PDMR Shareholding
5th Jun 20187:00 amRNSInterim Results
3rd May 20187:00 amRNSNotification of Half Year Results
6th Apr 20187:00 amRNSHalf Year Trading Update
3rd Apr 20184:35 pmRNSPrice Monitoring Extension
20th Mar 20188:25 amRNSHolding(s) in Company
21st Feb 20185:20 pmRNSResult of AGM
21st Feb 20187:00 amRNSAGM Trading Update
22nd Jan 20181:00 pmRNSDirector/PDMR shareholding
22nd Jan 20181:00 pmRNSDirector/PDMR shareholding
22nd Jan 20181:00 pmRNSDirector/PDMR shareholding
22nd Jan 20181:00 pmRNSDirector/PDMR shareholding
18th Jan 20181:35 pmRNSGrant of LTIP Awards
22nd Dec 20179:13 amRNSBlock Listing Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.